Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Treatment of human hepatoma and primary human hepatocyte cultures (PHH) with fatty acids and/or fatty acids and TNFa

ABSTRACT: Treatment of the human hepatoma cell lines HepG2, HUH7 and PHH with a mixture of fatty acids caused heaptic steatosis. The combined lipid and TNFa treatment mimics inflammation. Cells were harvested and processed for microarray analysis

ORGANISM(S): Homo sapiens

PROVIDER: GSE122660 | GEO | 2018/12/19

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Treatment of human hepatoma and primary human hepatocyte cultures (PHH) with fatty acids and/or fatty acids and TNFa

Project description:Treatment of human hepatoma and primary human hepatocyte cultures (PHH) with fatty acids and/or fatty acids and TNFa

| PRJNA505892 | ENA

Gene expression profiles in PHH-iPSCs, PHH-HLCs, PHHs, and HepG2

Project description:Interindividual differences in hepatic metabolism, which are mainly due to genetic polymorphism in its gene, have a large influence on individual drug efficacy and adverse reaction. Hepatocyte-like cells (HLCs) differentiated from human induced pluripotent stem (iPS) cells have the potential to predict interindividual differences in drug metabolism capacity and drug response. However, it remains uncertain whether human iPSC-derived HLCs can reproduce the interindividual difference in hepatic metabolism and drug response. We found that cytochrome P450 (CYP) metabolism capacity and drug responsiveness of the primary human hepatocytes (PHH)-iPSHLCs were highly correlated with those of PHHs, suggesting that the PHH-iPS-HLCs retained donor-specific CYP metabolism capacity and drug responsiveness. We also demonstrated that the interindividual differences, which are due to the diversity of individual SNPs in the CYP gene, could also be reproduced in PHH-iPS-HLCs. We succeeded in establishing, to our knowledge, the first PHH-iPS-HLC panel that reflects the interindividual differences of hepatic drugmetabolizing capacity and drug responsiveness.

2014-11-12 | GSE61287 | GEO

Impact of COP1 silencing on hepatoma and hepatocyte transcriptomics

Project description:Transfection experiments aimed at understanding the role of COP1 in hepatocytes and hepatoma models

2022-11-01 | GSE206116 | GEO

Human Hepatocyte Proteome - In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes

Project description:Here we report a comprehensive proteomic analysis of purified human hepatocytes and a human hepatoma cell line HepG2. The complete dataset comprises 9,400 proteins and provides quantitative depiction of the proteomes of hepatocytes and HepG2 cells at the protein titer and copy number dimensions.

2016-01-26 | PXD001874 | Pride

Protein data in PHH after VPA-treatment

Project description:LC-MS/MS protein data of Primary Human Hepatocytes (PHH) exposed to Valproic Acid (VPA) for 3 days daily and 3 days daily exposure followed by 3 days washout.

2018-02-27 | PXD007538 | Pride

ChIP-Seq data of H3K79succ modification of mononuclear bodies in PHH cells infected with HBV

Project description:Cell: HBV-infected PHH cells. Methods: PHH cells were infected with 2000 genome equivalents/cell of HBV particles in the presence of 4% PEG8000. Seven days after HBV infection, ChIP-Seq analysis of cccDNA in HBV-infected PHHs was carried out. HBV-infected PHH cells were digested with micrococcal nuclease and resulting mononucleosomes purified by sucrose gradient centrifugation. Nucleosomes were enriched with anti-H3K79succ antibodies by ChIP assay and the associated DNA contained both human and HBV DNA fragments was analyzed by deep sequencing. The HBV-specific reads in ChIP-Seq pilot experiments was quantified and normalized by the reads mapped to the human genome.

2021-11-14 | GSE188634 | GEO

Proteomic analyisis of cultured human podocytes stimulated with TNFa - supernatant

Project description:TNFa stimulated human cultured podocytes compared with unstimulated (vehicle control (VC)) podocytes. Incubation of podocytes with high concentrations of TNF alpha led to an overexpression of ICAM1 in particular. We studied this system as a comparator for organoids also stimulated with the same concentration of TNFa. Four conditions (6 replicates each) 1) treatment (5 ng/mL TNFa) for 24 hours 2) control (PBS) for 24h 3) treatment (5 ng/mL TNFa) for 48 hours 4) control (PBS) for 48h

2023-05-19 | PXD032130 | Pride

Proteomic analyisis of cultured human podocytes stimulated with TNFa - cell pellet

2023-05-19 | PXD032107 | Pride

Expression data from HCV infected hepatoma carcinoma cell line Huh7-MAVSR cells

Project description:Expression data from HCV infected hepatoma carcinoma cell line Huh7-MAVSR cells

| PRJNA433419 | ENA

DEPC labeling of TNFa - antibody complexes

Project description:Covalent labeling mass spectrometry measurements of complexes of tumor necrosis alpha (TNFa) with different antibodies.

2021-11-12 | MSV000088376 | MassIVE